Get the Stockscreener App
1.20
7.69%
-0.10
Myomo Inc stock is traded at $1.20, with a volume of 337.79K.
It is down -7.69% in the last 24 hours and down -6.98% over the past month.
Myomo, Inc., a commercial stage medical robotics company, designs, develops, and produces myoelectric braces or orthotics for people suffering with neuromuscular disorders in the United States. It offers MyoPro, a powered upper limb orthosis that supports the arm, as well as restores function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, ALS, or other neuromuscular disease or injury. The company serves orthotics and prosthetics practices or clinics, as well as the veteran administration and other hospitals through orthotics and prosthetics providers, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.
See More
Previous Close:
$1.30
Open:
$1.32
24h Volume:
337.79K
Relative Volume:
1.17
Market Cap:
$47.53M
Revenue:
$41.21M
Net Income/Loss:
$-15.12M
P/E Ratio:
-3.3343
EPS:
-0.3599
Net Cash Flow:
$-17.19M
1W Performance:
-16.08%
1M Performance:
-6.98%
6M Performance:
+51.13%
1Y Performance:
+11.11%
1-Day Range:
$1.20
$1.33
1-Week Range:
$1.20
$1.45
52-Week Range:
$0.605
$1.885
Myomo Inc Stock (MYO) Company Profile
Name
Myomo Inc
Sector
Industry
Phone
617-996-9058
Address
One Broadway, 14th Floor, Cambridge, MA
Compare MYO vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MYO
Myomo Inc
|
1.20 | 47.53M | 41.21M | -15.12M | -17.19M | -0.3599 |
ABT
Abbott Laboratories
|
104.89 | 181.50B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.75 | 121.20B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
294.66 | 113.02B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.39 | 64.33B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.60 | 49.92B | 6.30B | 1.07B | 1.09B | 1.8406 |
Myomo Inc Stock (MYO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-24 | Initiated | Craig Hallum | Buy |
| May-20-24 | Initiated | Lake Street | Buy |
| Dec-15-23 | Initiated | H.C. Wainwright | Buy |
| Nov-11-20 | Upgrade | ROTH Capital | Neutral → Buy |
| May-27-20 | Initiated | Dougherty & Company | Buy |
| Oct-02-17 | Initiated | H.C. Wainwright | Buy |
View All
Myomo Inc Stock (MYO) Latest News
Form 4 Myomo Inc: Harry Kovelman (Chief Medical Officer) For: 11 September - Investing.com Nigeria
Myomo CMO Harry Kovelman sells $20,136 in company stock By Investing.com - Investing.com Nigeria
Myomo CEO Paul R. Gudonis Awarded 71,250 RSUs on October 13, 2026 - Kalkine Media
Form 4 Myomo Inc: David A. Henry (CFO) For: 9 October - Investing.com Nigeria
Form 4 Myomo Inc: David A. Henry (CFO) For: 9 October - Investing.com Canada
To pay taxes only, Myomo (MYO) officer plans to sell 3,133 shares as stock grants vest. - Stock Titan
Form 4 Myomo Inc: Mary-Katherine Hale McClure (Chief Commericial Officer) For: 12 October - Investing.com India
Myomo appoints Mary-Katherine McClure as chief commercial officer - Investing.com
Myomo names new chief commercial officer effective October 2026 - StreetInsider
Myomo Appoints Mary-Katherine McClure as Chief Commercial Officer - Yahoo Finance
Q1 2025 Myomo Inc Earnings Call Transcript - GuruFocus
Q3 2025 Myomo Inc Earnings Call Transcript - GuruFocus
Myomo Inc (HAM:0M61) DCF Valuation - GuruFocus
Myomo Inc (HAM:0M61) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Myomo Inc Stock Operating Data - GuruFocus
Myomo Inc (HAM:0M61) Stock Price, Trades & News - GuruFocus
Spotlight On 3 Penny Stocks With Market Caps As Low As $10M - Simply Wall Street
Tangible book value per share of Myomo, Inc. – HAN:0M61 - TradingView
Discontinued operations of Myomo, Inc. – HAN:0M61 - TradingView
Preferred dividends of Myomo, Inc. – HAN:0M61 - TradingView
0M61 Forecast — Price Target — Prediction for 2027 - TradingView
Myomo Q2 2026 Earnings Call Transcript - Benzinga
ETFs Investing in Myomo, Inc. Stocks - TradingView
Myomo Inc (MYO) Chief Medical Officer Harry Kovelman Sells 15,48 - GuruFocus
Myomo (NYSE: MYO) insider to sell 15,844 shares after two recent sales - Stock Titan
Director of Myomo (NYSE: MYO) moves to sell shares from recent stock awards - Stock Titan
Myomo Inc. (MYO) Slips 0.7% to $1.42 as Shares Consolidate Within Narrow Trading RangeFactor Valuation - vinanet.vn
MYO Q2 2026 Earnings: EPS Miss of 18.81% Sends Shares Down 4.9%Earnings Decline Risk - vinanet.vn
Myomo Inc. (MYO) Slips 0.7% to $1.42 as Shares Consolidate Within Narrow Trading RangeZero Lag EMA - dars.gov.et
Myomo to Present at the H.C. Wainwright 28th Annual Global Investment Conference - BioSpace
Myomo to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance
Myomo Leads The Pack Of 3 Promising Penny Stocks - simplywall.st
Ascendiant Maintains Myomo(MYO.US) With Buy Rating, Raises Target Price to $10.5 - Moomoo
Myomo CMO Harry Kovelman sells $30,329 in stock By Investing.com - Investing.com Nigeria
Myomo CMO Harry Kovelman sells $30,329 in stock By Investing.com - Investing.com India
Myomo CMO Harry Kovelman sells $30,329 in stock - Investing.com
Myomo (MYO) Latest: Moves 0.57% Lower to $1.73 on the Day; Technical View - vinanet.vn
Myomo (MYO) Q2 2026 Results: Profit Per Share Falls Below Its Benchmark for This Review; Market Reaction: The Stock Loses 0.57% for the Current SessionGross Profit Margin - vinanet.vn
Myomo (MYO) Q2 2026 Results: Profit Per Share Falls Below Its Benchmark for This Review; Market Reaction: The Stock Loses 0.57% for the Current SessionEarnings Yield Analysis - dars.gov.et
Myomo chief medical officer sells $29,895 in shares - Investing.com India
Insider Selling: Myomo (NYSEAMERICAN:MYO) Insider Sells 17,250 Shares of Stock - MarketBeat
Myomo chief medical officer sells $29,895 in shares - Investing.com
Myomo chief medical officer sells $29,895 in shares By Investing.com - Investing.com South Africa
Myomo (NYSE: MYO) officer eyes 17,500-share stock sale - Stock Titan
Rosalind Advisors, Inc. Expands Myomo Inc (MYO) Stake -- Shares Trade 48% Below GF Value - GuruFocus
Myomo (MYO) Shows Fast-paced Momentum But Is Still a Bargain Stock - qz.com
Myomo Inc. (MYO) Q2 2026 Earnings: EPS Misses Estimates as Loss Deepens, Shares Edge Up - Vinanet
Myomo (MYO): Rosalind Master Fund reports 9.18% stake and warrant blocker - Stock Titan
Q1 2026 Myomo Inc Earnings Call Transcript - GuruFocus
Myomo Inc. (MYO) Q2 2026 Earnings: EPS Misses Estimates as Loss Deepens, Shares Edge UpEstimate Dispersion - dars.gov.et
Myomo Inc Stock (MYO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Myomo Inc Stock (MYO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| HARRY KOVELMAN | Officer |
Sep 11 '26 |
Proposed Sale |
1.27 |
15,844 |
20,136 |
0 |
| Kovelman Harry | Chief Medical Officer |
Sep 11 '26 |
Sale |
1.27 |
15,488 |
19,684 |
90,245 |
| Morris Milton Mayo | Director |
Sep 02 '26 |
Proposed Sale |
1.41 |
15,000 |
21,150 |
0 |
| Morris Milton Mayo | Director |
Sep 02 '26 |
Sale |
1.41 |
15,000 |
21,150 |
208,391 |
| Kovelman Harry | Chief Medical Officer |
Aug 20 '26 |
Sale |
1.73 |
17,250 |
29,896 |
105,983 |
| HARRY KOVELMAN | Officer |
Aug 20 '26 |
Proposed Sale |
1.73 |
17,500 |
30,329 |
0 |
| David Henry | Officer |
Jul 13 '26 |
Proposed Sale |
1.09 |
5,166 |
5,631 |
0 |
| Micah Mitchell | Officer |
Jun 12 '26 |
Proposed Sale |
1.20 |
9,061 |
10,873 |
0 |
| Harry Kovelman | Officer |
Jun 12 '26 |
Proposed Sale |
1.20 |
10,442 |
12,530 |
0 |
| Micah Mitchell | Officer |
Jun 08 '26 |
Proposed Sale |
1.33 |
6,529 |
8,684 |
0 |
1.95%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):